Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Motor Activity 32Breast Neoplasms 21Neoplasms 17Prostatic Neoplasms 11Obesity 8Colorectal Neoplasms 6Sarcopenia 5Pancreatic Neoplasms 5Lung Neoplasms 5Polycystic Ovary Syndrome 4Head and Neck Neoplasms 4Signs and Symptoms 3Multiple Myeloma 3Lymphedema 3Inflammation 3Fatigue 3Diabetes Mellitus, Type 2 3Colonic Neoplasms 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Pharyngeal Neoplasms 2Overweight 2Osteoporosis, Postmenopausal 2Osteoporosis 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Insulin Resistance 2Endometrial Neoplasms 2

Interventions

Echocardiography 14Doxorubicin 10Exercise 8Electrocardiography 7Trastuzumab 6Cyclophosphamide 5Carvedilol 5Docetaxel 3Atorvastatin 3salicylhydroxamic acid 2sacubitril and valsartan sodium hydrate drug combination 2empagliflozin 2dapagliflozin 2Tablets 2Social Determinants of Health 2Silymarin 2Magnetic Resonance Spectroscopy 2Ivabradine 2High-Intensity Interval Training 2Exercise Test 2Chemoradiotherapy 2Blood Specimen Collection 2Bisoprolol 2Antineoplastic Agents 2Anthracyclines 2sulforaphane 1schizandrin 1pegfilgrastim 1nicotinamide-beta-riboside 1mitoquinone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cardiotoxicity × Resistance Training × Clear all
NCT04036032 2025-10-14

Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy

Connecticut Children's Medical Center

Completed
47 enrolled

Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡